Literature DB >> 12686203

Vitrification of ECV304 cell suspensions using solutions containing propane-1,2-diol and trehalose.

Monica C Wusteman1, David E Pegg, Li-Hong Wang, Martin P Robinson.   

Abstract

In this paper, we report on the suitability of solutions containing propane-1,2-diol (propylene glycol, PD), sugars, and salts for the vitrification of the human cell line, ECV304. Cooling (at 10 degrees C/min) and rewarming (at 80 degrees C/min) were at rates that are practicable for the tissues to be studied later. Under these conditions, 45% PD in phosphate-buffered saline (PBS) sometimes froze during cooling and always devitrified during rewarming but both events were avoided if the PBS salts were replaced by an osmotically equivalent concentration of sucrose or trehalose. The effect of such solutions on cells was evaluated using a cell culture assay in which the number of cells recovered after 3 days of culture was divided by the number cells plated, giving a cell multiplication factor or CMF. In the absence of PD the cells tolerated a low-salt concentration in solutions that were made isotonic with sugars, but they recovered poorly when 45% PD was also present. Trehalose gave significantly better recovery than sucrose. When 39% PD and 15% trehalose were included in a low-salt vehicle solution (LSV) that contained approximately 5% of the total salt concentration of PBS (this solution was designated LSV/39/15), the cells exhibited approximately 40% of untreated control CMF following exposure for 9min. LSV/39/15 vitrifies with a glass transition temperature of -102 degrees C, does not devitrify when warmed at 80 degrees C/min, and has suitable dielectric properties for uniform and rapid dielectric heating. An improved method for adding and removing LSV/39/15 gave a CMF of approximately 55% of untreated controls. Using this method, 1.0ml suspensions of ECV304 cells was cooled to, and stored briefly at, -120 degrees C and then rewarmed by immersion in a 37 degrees C water bath ( approximately 75 degrees C/min). The CMF of the cooled samples was similar to that of the exposure-only controls, approximately 50% of the untreated control CMF in both cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686203     DOI: 10.1016/s0011-2240(03)00019-1

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  6 in total

1.  Development of sperm vitrification protocols for two endangered salmonid species: the Adriatic grayling, Thymallus thymallus, and the marble trout, Salmo marmoratus.

Authors:  Eszter Kása; Jelena Lujić; Zoran Marinović; Tímea Kollár; Gergely Bernáth; Zoltán Bokor; Béla Urbányi; Kinga Katalin Lefler; Dušan Jesenšek; Ákos Horváth
Journal:  Fish Physiol Biochem       Date:  2018-05-19       Impact factor: 2.794

2.  Vitrification by ultra-fast cooling at a low concentration of cryoprotectants in a quartz micro-capillary: a study using murine embryonic stem cells.

Authors:  Xiaoming He; Eric Y H Park; Alex Fowler; Martin L Yarmush; Mehmet Toner
Journal:  Cryobiology       Date:  2008-03-30       Impact factor: 2.487

3.  High-Throughput Non-Contact Vitrification of Cell-Laden Droplets Based on Cell Printing.

Authors:  Meng Shi; Kai Ling; Kar Wey Yong; Yuhui Li; Shangsheng Feng; Xiaohui Zhang; Belinda Pingguan-Murphy; Tian Jian Lu; Feng Xu
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

4.  Vitrification of Dog Skin Tissue as a Source of Mesenchymal Stem Cells.

Authors:  Young-Bum Son; Yeon Ik Jeong; Sang-Yun Lee; Yeon Woo Jeong; Ki-June Lee; Woo Suk Hwang
Journal:  Biomed Res Int       Date:  2021-07-10       Impact factor: 3.411

5.  Mathematically optimized cryoprotectant equilibration procedures for cryopreservation of human oocytes.

Authors:  Allyson Fry Davidson; James D Benson; Adam Z Higgins
Journal:  Theor Biol Med Model       Date:  2014-03-20       Impact factor: 2.432

6.  Reversible Cryopreservation of Living Cells Using an Electron Microscopy Cryo-Fixation Method.

Authors:  Jan Huebinger; Hong-Mei Han; Markus Grabenbauer
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.